TUMOR INFILTRATING LYMPHOCYTES AND PROGRAMMED DEATH LIGAND 1 (PD-L1) EXPRESSION IN DIFFUSE AND ANAPLASTIC GLIOMAS

被引：0
|
作者：
Berghoff, A. S. [1 ]
Kiesel, B. [2 ]
Widhalm, G. [2 ]
Wilhelm, D. [1 ]
Rajky, O. [1 ]
Kurscheid, S. [3 ]
Hegi, M. [4 ]
Woehrer, A. [5 ]
Marosi, C. [1 ]
Preusser, M. [1 ]
机构：
[1] Med Univ Vienna, Dept Med, Vienna, Austria
[2] Med Univ Vienna, Dept Neurosurg, Vienna, Austria
[3] Australian Natl Univ, John Curtin Sch Med Res, Dept Genome Sci, Canberra, ACT, Australia
[4] Univ Lausanne Hosp, Dept Clin Neurosci, Serv Neurosurg, Lab Brain Tumor Biol & Genet, Lausanne, Swaziland
[5] Med Univ Vienna, Inst Neurol, Vienna, Austria
来源：
NEURO-ONCOLOGY | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P04.09
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [21] Programmed Death Ligand 1 (PD-L1) Expression in Cervical Cancer
    Aryakrishna S. Lathika
    S. Lakshmi
    Preethi T. Ramdas
    Aswin Kumar
    Susan Mathews
    John Joseph
    Aleyamma Mathew
    Francis V. James
    Indian Journal of Gynecologic Oncology, 2021, 19
  • [22] Programmed death ligand 1 (PD-L1) expression in parathyroid tumors
    Pan, Boju
    Wang, Anqi
    Pang, Junyi
    Zhang, Yuhan
    Cui, Ming
    Sun, Jian
    Liang, Zhiyong
    ENDOCRINE CONNECTIONS, 2019, 8 (07) : 887 - 897
  • [23] Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor
    Valentine Suteau
    Alexandre Collin
    Philippe Menei
    Patrice Rodien
    Marie-Christine Rousselet
    Claire Briet
    Cancer Immunology, Immunotherapy, 2020, 69 : 2053 - 2061
  • [24] Programmed Cell Death 1 Ligand 1 (PD-L1) Expression in Thymoma
    Yokoyama, Shintaro
    Miyoshi, Hiroaki
    Nishi, Tatsuya
    Matsumoto, Ryouichi
    Hashiguchi, Toshihiro
    Murakami, Daigo
    Kashihara, Masaki
    Takamori, Shinzo
    Akagi, Yoshito
    Ohshima, Koichi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S503 - S503
  • [25] Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor
    Suteau, Valentine
    Collin, Alexandre
    Menei, Philippe
    Rodien, Patrice
    Rousselet, Marie-Christine
    Briet, Claire
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (10) : 2053 - 2061
  • [26] Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer
    Cantara, Silvia
    Bertelli, Eugenio
    Occhini, Rossella
    Regoli, Mari
    Brilli, Lucia
    Pacini, Furio
    Castagna, Maria Grazia
    Toti, Paolo
    ENDOCRINE, 2019, 64 (01) : 122 - 129
  • [27] Tumor budding in gastric adenocarcinoma; reflections on tumor microenvironment and programmed death ligand 1 (PD-L1) expression
    Khalek, Safaa M. M. Abd El
    Halim, Mariam I.
    IMMUNOPATHOLOGIA PERSA, 2023, 9 (01):
  • [28] Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer
    Silvia Cantara
    Eugenio Bertelli
    Rossella Occhini
    Marì Regoli
    Lucia Brilli
    Furio Pacini
    Maria Grazia Castagna
    Paolo Toti
    Endocrine, 2019, 64 : 122 - 129
  • [29] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE CARCINOSARCOMAS
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 219 - 219
  • [30] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE CARCINOSARCOMAS
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1125 - 1125
12345